Rheumatology

Whole-body cryotherapy significantly improves pain, function, and disease activity in patients with ankylosing spondylitis, a new meta-analysis finds.

Gout inflammation may follow a timed molecular sequence that opens distinct therapeutic windows for phase-specific treatment.

Lupus nephritis biomarkers remain a major area of interest, but few currently show enough evidence to reflect kidney histopathology and support clinical use.

Rheumatoid arthritis risk criteria may help identify which patients with arthralgia are most likely to progress.

Long-term secukinumab treatment preserved bone structure and controlled disease activity in psoriatic arthritis over 48 months.

Nanotechnology therapeutics may improve autoimmune disease treatment by enhancing targeting, lowering toxicity, and enabling immune modulation.

Sjögren’s disease linked to higher cancer risk in patients and close relatives in this cohort study.

Gout biomarkers linked to lipids, amino acids, and genes may help refine future therapeutic targeting. Read more.